Helicobacter Pylori as a Contributory Factor in Gallstone Disease: A Cross-Sectional Observational Study
International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)
DOI: 10.25258/ijcpr.18.7.236 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Shaffi Sharma und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Gallstone disease is among the commonest surgical disorders of the digestive tract, yet its classical risk factors do not fully account for who develops stones. Helicobacter pylori, long established as a gastric pathogen, has increasingly been recovered from bile and gallbladder tissue, raising the possibility that it contributes to lithogenesis. We examined how often H. pylori is present in patients with gallstone disease and whether its presence relates to stone composition and clinical features.
Methods
This cross-sectional observational study enrolled 85 adults with ultrasonographically proven cholelithiasis admitted for elective cholecystectomy at a tertiary teaching hospital in Jaipur. Before surgery every patient underwent upper gastrointestinal endoscopy with a dry rapid urease test (RUT) on antral biopsy; infection was additionally assessed by serum IgG, stool antigen, bile antigen and gallbladder mucosal histopathology. Stones retrieved at operation were typed biochemically. Associations were tested with the chisquare or Fisher exact test, with p < 0.05 considered significant.
Results
The mean age was 42.8 ± 11.6 years and women predominated (68.2%; p = 0.001). Gastric RUT was positive in 56.5% of patients, serum IgG in 63.5%, stool antigen in 44.7%, bile antigen in 30.6% and gallbladder histopathology in only 9.4%. Cholesterol stones were commonest (61.2%). RUT positivity was higher among patients with cholesterol stones (65.4%) than pigment (42.9%) or mixed (42.1%) stones, a difference that fell just short of significance (p = 0.054). Infection was not associated with stone number (p = 0.396) or clinical category (p = 0.734). Against RUT, serum IgG was sensitive (85.4%) but less specific, whereas histopathology was highly specific but insensitive (14.6%).
Conclusion
H. pylori is common in patients with gallstone disease and shows a consistent trend toward cholesterol stones, suggesting a contributory rather than causal role. Rapid urease testing and serology outperform conventional histopathology for detection. Larger, molecular-based studies are needed to confirm causality.
Zitieren
APA
Sharma, S., Vyas, N., Rao, R. S., & Joshi, S. (2026). Helicobacter Pylori as a Contributory Factor in Gallstone Disease: A Cross-Sectional Observational Study. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.236
Vancouver
Sharma S, Vyas N, Rao RS, Joshi S. Helicobacter Pylori as a Contributory Factor in Gallstone Disease: A Cross-Sectional Observational Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.236
BibTeX
@article{Sharma2026,
author = {Sharma, Shaffi and Vyas, N.L. and Rao, Randhir Singh and Joshi, Shrusti},
title = {Helicobacter Pylori as a Contributory Factor in Gallstone Disease: A Cross-Sectional Observational Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {07},
doi = {10.25258/ijcpr.18.7.236}
}
EUVIMED